Latest News
Vistance Shares Slip 42.7% Premarket on $5 Payout, $150M Buyback Expansion
Vistance (VISN) shares dropped 42.7% premarket after a $5 special dividend and $150M buyback expansion. Adjusted for the payout, value is slightly higher, but margin pressures persist.
BioXcel Therapeutics Files Chapter 11; Shares Plunge 62%
BioXcel Therapeutics (BTAI) filed for Chapter 11 bankruptcy, sending shares down 62.4% to $0.27. The company's liabilities ($100M-$500M) far exceed its assets ($10M-$50M), leaving common equity subordinate.
Dollar Tree Stock Drops on Weak Q3 Profit Forecast
Dollar Tree shares slid 3.9% after the retailer issued a disappointing Q3 earnings outlook, overshadowing a solid Q2 performance boosted by tariff refunds.
Dollar General Stock Rises on Traffic Gains, Raised Outlook
Dollar General shares climbed 2.5% after reporting stronger traffic and raising its full-year profit forecast, despite tariff-related gains boosting EPS.
Okta Stock Soars 28.6% on Strong Backlog Growth and Raised Guidance
Okta's stock surged 28.6% as cRPO growth accelerated to 14% and the company lifted its free cash flow outlook, reflecting strong demand for identity management.
Biohaven Shares Slide 5% as Raymond James Slashes Target on Opakalim Deal
Biohaven (BHVN) shares dropped 4.9% to $16.12 after Raymond James cut its price target to $30 from $50, citing the opakalim licensing deal that brings $400M cash but reduces upside.
Braskem ADRs Jump 10.8% on Petrobras Credit Boost
Braskem ADRs surged 10.8% after Petrobras increased its supplier credit line to R$2.35 billion, providing working capital as the company restructures $10.9 billion in debt.
FTSE Edges Higher as Miners Rally, Defence Stocks Slip
Miners and 3i lift FTSE 100, but defence names slide as investors await Fed's Warsh speech. Mid-caps also firm.
DraftKings Slides 2.3% as NFL Renews Rivalry with FanDuel Ahead of $30B Season
DraftKings shares dropped 2.3% after the NFL renewed partnerships with FanDuel and added Fanatics. The league's $30 billion betting season begins September 9.
Salesforce Soars 22.6% as AI Revenue Hits $3.9 Billion
Salesforce (CRM) surged 22.6% after AI and Data ARR hit $3.9 billion, up 210%, with revenue up 11% and free cash flow up 81%.
Celularity Shares Surge 138% on $300M MuseCell Manufacturing Forecast
Celularity (CELU) shares jumped 138.5% after projecting $300M in MuseCell manufacturing revenue, but the company faces cash constraints and going-concern doubts.
Intel Gains 4.4% as Nvidia's Optimistic Forecast Boosts AI Chip Sentiment
Intel shares climbed 4.4% to $92.09 following Nvidia's bullish revenue forecast, which eased concerns about AI infrastructure spending. However, the stock remains below its recent $95 equity offering price.